These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1770115)

  • 1. [An immunohistochemical study and its clinical application for endocrine disorders using monoclonal antibodies].
    Shimizu K; Eisenbarth GS; Shoji T
    Nihon Ika Daigaku Zasshi; 1991 Dec; 58(6):615-20. PubMed ID: 1770115
    [No Abstract]   [Full Text] [Related]  

  • 2. The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.
    Rosa P; Gerdes HH
    J Endocrinol Invest; 1994 Mar; 17(3):207-25. PubMed ID: 8051343
    [No Abstract]   [Full Text] [Related]  

  • 3. Classic and recent special stains used in differential diagnosis of endocrine tumors.
    Bussolati G; Volante M; Papotti M
    Endocr Pathol; 2001; 12(4):379-87. PubMed ID: 11914471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endocrine tumor].
    Sasano H
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):121-4. PubMed ID: 15675597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Breast and endocrine tumor].
    Toi M
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2338. PubMed ID: 19117100
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene expression profiling of endocrine tumors using DNA microarrays: progress and promise.
    Giordano TJ
    Endocr Pathol; 2003; 14(2):107-16. PubMed ID: 12858000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the evaluation of proliferative activity predict malignancy of prognosis in endocrine tumors?
    DeLellis RA
    Hum Pathol; 1995 Feb; 26(2):131-4. PubMed ID: 7860041
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunohistochemical diagnosis by means of tyramide signal amplification].
    Qvigstad G; Falkmer S; Waldum HL
    Tidsskr Nor Laegeforen; 2000 Jan; 120(2):236-8. PubMed ID: 10851922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computed tomographic, magnetic resonance, and monoclonal antibody imaging of endocrine tumors.
    Radecki PD
    Curr Opin Oncol; 1993 Jan; 5(1):91-9. PubMed ID: 8427896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criteria and markers for malignancy in endocrine tumors.
    de Krijger RR
    Endocr Pathol; 2006; 17(2):107-8. PubMed ID: 17159242
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment for breast cancer and endocrine neoplasm].
    Takada M; Ishiguro H; Toi M
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2344-50. PubMed ID: 19117102
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibody (HML-1) labelling of T-cell lymphomas.
    Lancet; 1989 Jan; 1(8631):223-4. PubMed ID: 2563134
    [No Abstract]   [Full Text] [Related]  

  • 13. Carbonic anhydrase IX expression in clear cell renal cell carcinomas negatively correlates with the proportion of the granular cell component.
    Skapa P; Hyrsl L; Zavada J; Soukup J; Zamecnik J
    J Clin Oncol; 2008 Aug; 26(22):3809-11; author reply 3811-2. PubMed ID: 18669473
    [No Abstract]   [Full Text] [Related]  

  • 14. Expect the unexpected.
    Macher-Goeppinger S; Longerich T; Hackert T; Andrulis M
    Int J Surg Pathol; 2010 Aug; 18(4):301. PubMed ID: 20627955
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical relevance of the expression of somatostatin receptors in digestive endocrine tumours.
    Capurso G; Panzuto F; Delle Fave G
    Dig Liver Dis; 2010 Mar; 42(3):173-4. PubMed ID: 20117969
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of the adenocarcinoma-related antigen recognized by monoclonal antibody 44-3A6 in salivary gland neoplasias.
    Bentz BG; Haines GK; vonSchlegell AS; Elseth KM; Hanson DG; Radosevich JA
    Otolaryngol Head Neck Surg; 1998 May; 118(5):603-9. PubMed ID: 9591857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody MON-114: detection of a marker for neuroendocrine differentiation in human lung cancer.
    van Duijnhoven HL; Moors EH; Groeneveld A; Timmer ED; de Leij LF; Wagenaar SS; Polak JM; van de Ven WJ
    Cancer Lett; 1992 Mar; 63(1):61-6. PubMed ID: 1313334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of monoclonal antibodies in the clinical management of epithelial ovarian carcinoma.
    Bast RC; Knapp RC
    Important Adv Oncol; 1987; ():39-53. PubMed ID: 3331386
    [No Abstract]   [Full Text] [Related]  

  • 19. OV632 as a possible marker for malignant mesothelioma: high expectations; low specificity.
    Abati A; Fetsch PA
    Diagn Cytopathol; 1995 Feb; 12(1):81-2. PubMed ID: 7789255
    [No Abstract]   [Full Text] [Related]  

  • 20. CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors.
    La Rosa S; Rigoli E; Uccella S; Chiaravalli AM; Capella C
    Virchows Arch; 2004 Sep; 445(3):248-54. PubMed ID: 15517368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.